Ondine Biomedical announces that its Phase 2 BENEFIT-APDT clinical trial has met the primary endpoint…
sciencecitySeptember 8, 2022
Having a peanut allergy can be hard: there are peanuts in many foods, cooking oils,…
sciencecitySeptember 8, 2022
An iconic Vancouver attraction, Stanley Park, is the backdrop to a 70-year-old cold case that…
Marjorie HendersonAugust 26, 2022
UBC’s School of Biomedical Engineering (SBME) and Amgen are pleased to announce the inaugural 2022…
sciencecityJune 15, 2022
Several neurological diseases are characterized by abnormal accumulation of short tandem repeat (STR) sequences. Today,…
sciencecityOctober 12, 2021
Clairvoyant Therapeutics (“Clairvoyant”), a Canadian biotech company focused on the development of psychedelic drug therapies…
sciencecityOctober 11, 2021
Acuitas Therapeutics, the Vancouver, BC-based biotech company co-founded by NMIN research leader Dr. Pieter Cullis, has…
sciencecityOctober 11, 2021
A drug commonly used to treat cancer can restore memory and cognitive function in mice…
sciencecityOctober 8, 2021
The Canada Biomedical Research Fund (CBRF) and Biosciences Research Infrastructure Fund (BRIF) are essential components…
sciencecityOctober 8, 2021
